News and Information
News and Information
From May 14th to 17th, the '2026 Chongqing-Sichuan Academic Annual Conference of the Dermatology and Gynecology Special Committee of the Chongqing Association of Integrated Traditional Chinese and Western Medicine' and the '2026 Academic Annual Conference of the Traditional Chinese Medicine Beauty Special Committee of the Chongqing Association of Traditional Chinese Medicine' came to a successful conclusion. Jin Pharmaceutical Co., Ltd. participated in the event with representative products of the skin care line, using academia to empower product innovation and leveraging professionalism to strengthen brand strength.

This grand event features two concurrent sessions that resonate at the same frequency, creating a high-level academic exchange platform for the integration of traditional Chinese and Western medicine in the field of dermatology. The conference focuses on the cutting-edge hotspots in the diagnosis and treatment of skin diseases and the field of traditional Chinese medicine for beauty. It brings together dermatology experts and scholars from both Chongqing and Sichuan regions, and delves into in-depth discussions on topics such as integrated traditional Chinese and Western medicine treatment techniques, the development and clinical application of topical preparations, etc., exchanging academic ideas and sharing research results.
As a company deeply engaged in the field of topical skin care preparations, Jin Pharmaceutical actively participates in academic exchanges and collaborates with industry experts to discuss clinical challenges and research directions. This helps to draw forward-thinking ideas for the continuous upgrading and iteration of products, further strengthening the academic foundation. During the conference, the company's core products such as Diclofenac Hydrochloride Cream (Yuzhuer), Chloroquine Iodine Hydrochloride Cream (Keailin), and the new product Diflucortol Oxalate Cream made a splendid appearance. With their excellent quality and definite efficacy, they received widespread recognition from the attending clinical experts.
In the future, Jin Pharmaceutical will continue to deeply focus on the field of skin topical preparations, closely aligning with clinical needs, promoting product innovation and transformation of achievements. Through practice, they will refine quality; through communication, they will build consensus. They will continuously provide patients with safer and more effective medication options, and strive to safeguard skin health.
Article: Health Technology